STATE OF WISCONSIN INVESTMENT BOARD - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 246 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$991,639
-14.9%
84,828
-2.1%
0.00%0.0%
Q2 2023$1,164,899
-23.0%
86,674
-5.0%
0.00%
-25.0%
Q1 2023$1,512,113
-17.0%
91,201
-6.9%
0.00%
-33.3%
Q4 2022$1,822,428
+42.7%
97,980
-1.5%
0.01%
+50.0%
Q3 2022$1,277,000
+73.5%
99,500
-5.2%
0.00%
+100.0%
Q2 2022$736,000
-33.0%
104,930
-20.7%
0.00%0.0%
Q1 2022$1,098,000
-5.5%
132,400
-22.9%
0.00%0.0%
Q4 2021$1,162,000
+65.5%
171,700
+29.7%
0.00%
+100.0%
Q3 2021$702,000
-7.8%
132,4000.0%0.00%
-50.0%
Q2 2021$761,000
+24.8%
132,4000.0%0.00%
+100.0%
Q1 2021$610,000
+38.0%
132,4000.0%0.00%0.0%
Q4 2020$442,0000.0%132,400
-11.1%
0.00%0.0%
Q3 2020$442,000
-35.8%
148,9000.0%0.00%
-50.0%
Q2 2020$688,000
+20.1%
148,9000.0%0.00%0.0%
Q1 2020$573,000
+5.5%
148,900
+2.9%
0.00%
+100.0%
Q4 2019$543,000
-29.3%
144,7000.0%0.00%
-50.0%
Q3 2019$768,000
+52.4%
144,700
+10.3%
0.00%
+100.0%
Q2 2019$504,000
-22.9%
131,200
+2.3%
0.00%
-50.0%
Q1 2019$654,000
+244.2%
128,300
+29.6%
0.00%
+100.0%
Q4 2018$190,000
-6.9%
99,000
+83.3%
0.00%0.0%
Q3 2018$204,000
+21.4%
54,0000.0%0.00%
Q2 2018$168,000
+30.2%
54,0000.0%0.00%
Q1 2018$129,000
-38.9%
54,0000.0%0.00%
-100.0%
Q4 2017$211,000
+55.1%
54,0000.0%0.00%
Q3 2017$136,000
-8.7%
54,0000.0%0.00%
Q2 2017$149,00054,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders